Experimental Hematology
Overview
Experimental Hematology is a renowned scientific journal that focuses on cutting-edge research in the field of hematology. It publishes original studies and reviews on experimental and clinical aspects of blood disorders, including hematopoiesis, stem cell biology, immunology, and transfusion medicine. With a multidisciplinary approach, this journal serves as a valuable resource for researchers, clinicians, and students interested in advancing our understanding and treatment of hematological diseases.
Details
Details
Abbr.
Exp Hematol
Start
1973
End
Continuing
Frequency
Twelve no. a year, 1999-
p-ISSN
0301-472X
e-ISSN
1873-2399
Country
Netherlands
Language
English
Specialty
Hematology
Metrics
Metrics
h-index / Ranks: 1957
129
SJR / Ranks: 3000
1157
CiteScore / Ranks: 4778
5.20
JIF / Ranks: 4138
2.6
Recent Articles
1.
Ding M, Lu Y, Lei Q, Zheng Y
Exp Hematol
. 2025 Mar;
:104752.
PMID: 40086687
Hematopoietic stem cell transplantation (HSCT) is an essential and increasing therapeutic approach for treating conditions such as leukemia, lymphoma, and other blood cancers. However, its widespread use faces significant challenges,...
2.
3.
Holmes S, Wells C, Hall C, McNaughton A, Rauh M, Abraham S
Exp Hematol
. 2025 Feb;
:104747.
PMID: 40015506
The precancerous expansion of hematopoietic cells, termed clonal hematopoiesis (CH), has been correlated to disease development and all-cause mortality. Despite multiple observations that hematopoietic stem cell and progenitors (HSPCs) are...
4.
Cisa-Wieczorek S, Cisa-Wieczorek S, Hernandez-Alvarez M, Hernandez-Alvarez M, Parreno M, Parreno M, et al.
Exp Hematol
. 2025 Feb;
145:104748.
PMID: 39986568
The KIT receptor is a transmembrane protein found on the surface of many different cell types. Mutant forms of KIT are drivers of myeloid neoplasms, including systemic mastocytosis. The KIT...
5.
Nakatani T, Nagasawa T
Exp Hematol
. 2025 Feb;
144:104749.
PMID: 39978750
Among various types of candidate cells, including osteoblasts and Nestin periarteriolar cells, several lines of histological and genetic evidence have demonstrated that the single population of mesenchymal stem cells, termed...
6.
Tachibana T, Izumi A, Arai S, Takeda T, Hirose N, Tamai Y, et al.
Exp Hematol
. 2025 Feb;
144:104746.
PMID: 39952596
The outcomes of patients with high-risk acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (HCT) remain poor despite many attempts at developing therapeutic strategies. Preconditioning interventions (PCIs) have...
7.
8.
Park C, Bridges C, Lewis A, Chen T, Shai S, Du W, et al.
Exp Hematol
. 2025 Feb;
144:104730.
PMID: 39900173
The transcription factor Krüppel-like factor 4 (KLF4) acts as a transcriptional activator and repressor. KLF4 plays a role in various cellular processes, including the dedifferentiation of somatic cells into induced...
9.
Hinchly T, Bonnet D, Anjos-Afonso F
Exp Hematol
. 2025 Feb;
144:104729.
PMID: 39892848
Recently, human CD34 hematopoietic stem cells (HSCs) have been purified to a frequency of approximately one in three cells, a population denoted as CD34CD38CD45RACD90 endothelial protein C receptor (EPCR) HSCs....
10.
Jenkins M, Chu Y, Franceski A, Potts C, Dubin R, Dickerson K, et al.
Exp Hematol
. 2025 Jan;
144:104727.
PMID: 39855457
Signaling responses to cytokines are disrupted in clonal hematopoiesis and myeloid malignancies. To better identify specific signaling response alterations in the presence or absence of TET2, we developed a 36-parameter...